Cipla Tops Q2 Profit View on Solid Domestic, N.America Sales
BENGALURU, Oct 27 Reuters Cipla, India39;s thirdlargest generic drugmaker by sales, posted a biggerthanexpected rise in secondquarter profit on Friday, boosted by strength in its key domestic and North American business. The company39;s consolidated net profit climbed 43.4 to 11.31 billion rupees 135.90 million in the quarter ended Sept. 30, beating analysts39; average estimate of […]